Literature DB >> 7577586

Venous leg ulcers and squamous cell carcinoma: a large-scale epidemiological study.

B Baldursson1, B Sigurgeirsson, B Lindelöf.   

Abstract

In order to obtain a precise estimate of the relative risk of squamous cell carcinoma (SCC) in venous leg ulcers, we matched 10,913 patients with the diagnosis venous leg ulcer from the Swedish Inpatient Registry with registrations of SCC of the lower limb recorded by the Swedish Cancer Registry, and found 33 cases of non-melanoma skin cancer. After scrutinizing the pathology and case records, 17 cases of SCC were considered as being certainly secondary to venous leg ulcers, whereas in six cases of remitting/relapsing ulcers the connection was probable. The relative risk calculated on 17 cases was 5.80 (95% confidence interval = 3.08-9.29). The median duration of the ulcer before the diagnosis of cancer was 25 years. The mean follow-up time of the cohort was 8.5 years. We conclude that SCC is a complication of chronic venous leg ulcers, although the absolute risk is very small.

Entities:  

Mesh:

Year:  1995        PMID: 7577586     DOI: 10.1111/j.1365-2133.1995.tb02707.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  [Ulcerous basal cell carcinoma on the lower leg. Differential diagnosis of ulcus cruris venosum: a report of 3 cases].

Authors:  O Kovnerystyy; J Reifenberger; K W Schulte; H Stege
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

2.  Malignant transformation of a chronic leg ulcer.

Authors:  Cornelia Erfurt-Berge; Gerold Schuler; Juergen Bauerschmitz
Journal:  Int Wound J       Date:  2009-06       Impact factor: 3.315

Review 3.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

4.  Marjolin ulcer: an overlooked entity.

Authors:  Sasha Pavlovic; Elizabeth Wiley; Grace Guzman; David Morris; Marylee Braniecki
Journal:  Int Wound J       Date:  2011-05-17       Impact factor: 3.315

5.  A multidisciplinary team approach to hydroxyurea-associated chronic wound with squamous cell carcinoma.

Authors:  Tamar Stone; Alexandra Berger; Sheila Blumberg; Daniel O'Neill; Frank Ross; Alexander McMeeking; Weiliam Chen; Irena Pastar
Journal:  Int Wound J       Date:  2011-11-17       Impact factor: 3.315

6.  Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.

Authors:  Shadmehr Demehri; Ahu Turkoz; Raphael Kopan
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

7.  [Marjolin's ulcer: malignant transformation of a crural ulcer due to posttraumatic chronic osteomyelitis].

Authors:  P Bula; J Bula-Sternberg; U Wollina; G Haroske; F Bonnaire
Journal:  Unfallchirurg       Date:  2010-02       Impact factor: 1.000

8.  Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.

Authors:  Maria H Lind; Björn Rozell; Robert P A Wallin; Max van Hogerlinden; Hans-Gustaf Ljunggren; Rune Toftgård; Inderpreet Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

Review 9.  Framing of research question using the PICOT format in randomised controlled trials of venous ulcer disease: a protocol for a systematic survey of the literature.

Authors:  Luciana P F Abbade; Mei Wang; Kamath Sriganesh; Lawrence Mbuagbaw; Lehana Thabane
Journal:  BMJ Open       Date:  2016-11-11       Impact factor: 2.692

10.  Sickle cell disease induces resistance to cutaneous carcinogenesis.

Authors:  Boutros Soutou; Patricia Senet; François Lionnet; Anoosha Habibi; Sélim Aractingi
Journal:  Orphanet J Rare Dis       Date:  2020-03-06       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.